Smart diet plan uses glucose monitors to help asian americans tame diabetes

NCT ID NCT07278531

Not yet recruiting Disease control Sponsor: NYU Langone Health Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 2 times

Summary

This study tests whether a personalized diet plan, guided by a continuous glucose monitor (CGM), can help Chinese and Vietnamese Americans with type 2 diabetes better control their blood sugar. 120 participants will either receive the adaptive diet program or standard care for 12 weeks, followed by 12 weeks of follow-up. The program starts with just the CGM, and if blood sugar doesn't improve, adds culturally tailored dietary coaching.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Continuous glucose monitor and personalized dietary advice
What this could lead to: If successful, this approach could offer a practical, culturally tailored way for Asian Americans with type 2 diabetes to better manage their blood sugar without extra medication.
What could go wrong: This is a small, early feasibility study (120 people) that primarily measures recruitment and retention, not long-term health outcomes. The intervention is complex and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES

Contacts and locations

Locations

NYU Langone Health

New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.